Q3 2023 Conference Call Replay
Listen to the replay of the Q3 2023 conference call
Quarterly Financial Results and Business Overview
The Nephros Q3 2023 conference call replay features Robert Banks, President and CEO of Nephros, and Judy Krandel, CFO. Mr. Banks presents an overview of the business over the last three months with additional insights on the commercial perspective and outlook for the future. Ms. Krandel provides detailed financial results for the third quarter.
Read the Q3 2023 press release as a complement to the conference call recording. An excerpt of the release is included below.
“Nephros has delivered high levels of sustained growth over the past three quarters, with gross margins up significantly from the same period last year,” said Robert Banks, President and Chief Executive Officer.
Robert Banks, President and Chief Executive Officer, continued, “In addition, our cash flows from operating activities in 2023 have been consistently positive, totaling $1.1 million so far this year. We remain laser-focused on financial growth and offering an effective and reliable solution for our infection control and dialysis customers. Furthermore, our commercial business continues to mature under the efficient operating model in place with Donastar. Overall, I am very encouraged.”
Judy Krandel, Chief Financial Officer, commented, “Year-to-date revenue growth was extremely strong this quarter, at 48% over the same period in 2022. Further, we believe our positive net cash flows are a good indicator of progress towards GAAP profitability, which we expect to achieve within the next few quarters.”
